SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-025341
Filing Date
2024-06-26
Accepted
2024-06-26 21:30:11
Documents
1
Period of Report
2024-06-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3996
  Complete submission text file 0001493152-24-025341.txt   5454
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Melincoff Gwen A (Reporting) CIK: 0001614890 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40237 | Film No.: 241075093

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)